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Background: Regional comparisons of cancer-related mortality in Germany are
traditionally focused on disparities between East and West Germany. Recent
improvements in all-cause and cancer-related mortality show a diverse regional
pattern beyond the known East-West mortality divide. A generalized approach of
the avoidable/amenable cancer mortality definition is applied for suitable regional
comparisons of long-term trends.
Methods: Standardized death rates of preventable and amenable cancer mortality for
men and women were computed for the period 1990–2014 to observe sex-specific
excess mortality due to specific cancers after the German reunification. For regional
comparison, three German super regions were defined in Eastern, Northwestern, and
Southwestern Germany to account for similarities in long-term regional premature and
cancer-related mortality patterns, socioeconomic characteristics, and age structure.
Results: Since preventable and amenable cancer mortality rates typically have driven
the recent trends in prematuremortality, our findings underline the current regional pattern
of preventable cancer mortality for males with disadvantages for Eastern Germany,
and advantages for Southwestern Germany. Among women, the preventable cancer
mortality has increased in Northwestern and Southwestern Germany after the German
reunification but has decreased in Eastern Germany and converged to the pattern of
Southwestern Germany. Similar patterns can be observed for females in amenable
cancer mortality.
Conclusions: Although the “traditional” East-West gap in preventable cancer
mortality was still evident in males, our study provides some hints for more regional
diversity in avoidable cancer mortality in women. An establishing north-south divide
in avoidable cancer mortality could alter the future trends in regional cancer-related
mortality in Germany.
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BACKGROUND
The regional variation in avoidable cancer mortality for Europe
is known as a northwest (NW) to southeast (SE) gradient with
higher mortality risk proportions for males (1–3). The NW to SE
gradient in Europe is also accounted by the increasing smoking-
related cancer incidence and the associated higher mortality risks
especially for men in Southeast Europe. Otherwise, in North and
West Europe, the cancer incidences tend to be stabilizing because
of lower smoking prevalence in men and improved breast cancer
screening technology in females (4).
On the regional level, Germany has experienced such
geographic variations, with dramatic gaps in cancer-related
mortality in the 1970s and 1980s. Prior to the German
reunification, the cancer mortality was almost higher in East
Germany, similar to the remaining mortality gap between
Southeast and Northwest Europe (4, 5).
Within the last 25 years, East Germany has passed through
an intensive economic and political alteration as well as the
assimilation of the health care system under the same conditions
of West Germany. This led to a partial adjustment of cancer
related mortality in East Germany to the level of West Germany.
Moreover, the regional pattern in avoidable cancer mortality
known as a northeast-southwest divide still remains (6–8).
Plausible explanations yield on a gender gap in avoidable cancer
mortality, which tends to be higher in Eastern Germany. That is
due to the remaining unfavorable life time risks in that region,
especially in its rural areas.
In Eastern Germany, especially in its northern part, men
potentially have higher risk of premature deaths because of less
willingness of healthcare screening, high smoking and alcohol
consumptions levels, overweight, and low physical activity (9–
11). These harmful health behaviors also correspond with social
factors and individual lifestyle choices in males.
Men in Eastern Germany are also more likely to be affected
from poorer socioeconomic conditions, including redundancy,
low income, and lower educational attainment that is also
associated with unhealthy behavior (12, 13).
After German reunification, Eastern Germany experienced an
increase of average life expectancy but also a decrease of birth
rates and selective emigration of young andwell-educated people,
each resulting in an accelerated population aging. Regions with
better job opportunities are attractive migration destinations.
So far, migration is accounted as a selective health mechanism,
with migrants usually being healthier than the stayers (14). In
addition, the east-west migration balance is particularly negative
among young women, resulting in a tremendous deficit in
females among young to middle-aged adults in the rural areas of
Eastern Germany (15).
The excess female emigration at county level can be explained
with gender disparities in educational attainment that favored
women (15). The female brain drain in Eastern Germany is also
accompanied with less availability of potential partners for men
(15, 16). The selective migration pattern accompanied by the
loss in positive health risk factors as well as the discrepancy
in sex-specific health behaviors are good indicators to explain
regional variation in avoidable cancer mortality. Therefore, we
use the gender gap in avoidable cancer mortality as a proxy
for regional variation in the distribution of biological and non-
biological factors (17, 18). Some studies argue that only 25%
of the sex differences in mortality are attributable to biological
differences (18). The major part can be explained by social and
behavioral factors, which are in turn influenced by biological
factors, however (19).
Themajor scope of our study was to analyze the regional long-
term trends in avoidable cancer mortality for the period since
the German reunification under consideration of a generalized
approach for the avoidable cancer mortality definition that is
suitable for the German regional perspective.
Moreover, we examined sex-specific disparities in avoidable
cancer mortality to explain recent trends to explain the recent
trends for three German super regions: Eastern, Northwestern,
and Southwestern Germany.
DATA AND METHODS
Different approaches were used in literature to account for
avoidable mortality that had involved different typologies of
premature death. Generally, avoidable mortality can be referred
to as a selection of causes of death that should be amenable
to health care (amenable mortality) or as a selection of causes
of death that should be avoidable through primary prevention
(preventable mortality) (20). There are many different concepts
of avoidable mortality but no commonly used classification of
avoidable cancer mortality that includes both amenable and
preventable conditions. Regarding the health service system and
the national health risk profile in Germany, we have therefore,
redistributed the avoidable cancer mortality classification to an
approach that is more suitable for the case of Germany. This
classification of avoidable cancer mortality and its division into
preventable and amenable cancers basically follows the concepts
of Nolte and McKee (21), Page et al. (22), Tobias et al. (23), Nolte
and McKee (24), and Mackenbach et al. (25).
In the first group of preventable cancer mortality, we selected
all cancer-related deaths that could be avoided or reduced
through effective inter-sectoral health policies by means of
primary prevention, especially with regard to smoking, unhealthy
diet, and alcohol consumption. This involved cancers of lip,
oral cavity, pharynx, esophagus, stomach, liver, larynx, lung,
bronchus, trachea, and bladder.
The second group of amenable cancer mortality includes all
cancer-related deaths that should be avoided or reduced through
timely and effective health care regarding both, diagnosis and
treatment. This involved cancers of colon and rectum, bone, skin,
eye, and thyroid as well as Hodgkin’s disease and leukemia and
the sex-specific cancers of female breast, cervix, uterus, prostate,
and testis (Table 1).
For data analysis, we used the cause of death data for the
period of 1990–2014 by sex, age, and regional level (16 German
Bundesländer) as well as the corresponding year-end population
numbers for the period of 1989–2014, provided by the Federal
Statistical Office. In order to avoid fluctuations, three year values
were used for all calculations. Thus, the analyses refer to the
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TABLE 1 | Selection of causes of death.
Cause of death Age ICD-9 ICD-10
Preventable cancer mortality Cancer of lip, oral cavity, pharynx 0–74 140–149 C00–C14
Cancer of esophagus 0–74 150 C15
Cancer of stomach 0–74 151 C16
Cancer of liver 0–74 155 C22
Cancer of larynxa 0–74 161 C32
Cancer of lung, bronchus and trachea 0–74 162 C33–C34
Cancer of bladderb 0–74 188 C67
Amenable cancer mortality Colorectal cancer 0–74 153–154 C18–C21
Bone cancerb 0–74 170 C40–1
Skin cancer 0–74 172, 173 C43, C44
Eye cancer 0–74 190 C69
Thyroid cancer 0–74 193 C73
Hodgkin’s disease 0–74 201 C81
Leukemiac 0–44 204–208 C91–C95
→ Women only Breast cancer 0–74 174 C50
Cervical cancer 0–74 180 C53
Uterine cancer 0–74 179, 182 C54, C55
→ Men only Prostate cancera 0–74 185 C61
Testicular cancer 0–74 186 C62
This classification is based on Page et al. (22), with the following exceptions:
aLaryngeal and prostate cancer were added according to Mackenbach et al. (25).
bBladder and bone cancer were added according to Tobias et al. (23).
cLeukemia group was widened according to Nolte and McKee (21, 24).
period from 1991 to 2013. The cause-specific death information
on cancer was followed to the International Classification of
Diseases (ICD) with ICD-9 codes up to 1997 and ICD-10 codes
from 1998 onwards. We defined the following age- groups: 0–
29, 30–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69, and 70–74
years to estimate the age-specific death rates for specific cancers.
The bounds of the first two age groups are broader due to the
comparatively low numbers of cancer deaths at young ages. Older
ages from 75 years upwards were not included “as “avoidability”
of death and reliability of death certification become increasingly
questionable at older ages” (21).
For regional comparisons, we defined three geographic
regions: Eastern, Northwestern, and Southwestern Germany
(Figure 1). This geographical grouping is based on minimal
internal group variation in the level of cancer mortality and its
development over time as well as similarities in socioeconomic
characteristics and age structure. Eastern Germany corresponds
to the territory of the former GDR (East Germany), however
including all of Berlin. Western Germany, thus excluding the city
of Berlin, was divided into a northern and southern part to take
account of systematic differences in mortality and socioeconomic
characteristics, which otherwise would be overlaid. Doing this,
both gradients, between north and south as well as between east
and west, can be addressed.
The rates of preventable and amenable cancer mortality for
men andwomenwere computed for the period from 1991 to 2013
to observe sex-specific differences in specific cancers after the
German reunification. We used standardized death rates to show
all-cause and cause-specific mortality differences over time and
between regions and sex. The main advantage of standardization
is that death rates are no longer distorted by differences or
changes in the age structure. Furthermore, standardized death
rates are additive: “the sum of death rates by cause equals the
death rate from all causes” (Meslé, 2006, p. 36) (26). Death
rates with a directly standardized age and sex structure were
therefore, computed for each region, differentiated by sex and
cause of death group, based on textbooks like Preston et al. (27)
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with SDRt being the standardized death rate at time t (in
years); Dx being the number of deaths at age x, Nx being the
age-specific year-end population size, and Cx being the age-
specific standard population. We chose the German 2011 Census
as standard population without disaggregation by sex. As a
statistical test for the standardized death rates, we calculated
95% confidence intervals according to Chiang (28), with the age-
specific probability of death computed according to Farr (29).
We interpreted mortality differences at time t as statistically
significant when the confidence intervals of two regions did
not overlap.
For relative comparison we used rate ratios from standardized
death rate estimates, with Southwestern Germany as the
reference population.
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FIGURE 1 | Composition of the study regions. Northwestern Germany: Bremen, Hamburg, Niedersachsen, Nordrhein-Westfalen, Rheinland-Pfalz, Saarland,
Schleswig-Holstein; Southwestern Germany: Baden-Württemberg, Bayern, Hessen; Eastern Germany: Brandenburg, Berlin, Mecklenburg-Vorpommern, Sachsen,
Sachsen-Anhalt, Thüringen. Base map: ©GeoBasis-DE/Bundesamt für Kartographie und Geodäsie.
RESULTS
Overall, we find declining trends in preventable and amenable
cancer mortality, comparable to the decrease in all-cause
premature mortality (see Figure A1). In addition, avoidable
cancer deaths contribute to one third of all premature deaths
among men and to almost half of all premature deaths among
women (see Table A1). Thus, we identify the decrease in
avoidable cancer mortality as one of the major drivers for the
decrease in German overall mortality at ages 0 to 74. The
avoidable cancer deaths in all-cause premature mortality in
Germany increased from 30 to 34% among men and rose from
41 to 48% among women between 1991 and 2013 due to the
stronger decrease in other premature deaths. This relative growth
is evident for all regions, but particularly for Eastern Germany,
which shows an increase from 25 to 33% among men and from
34 to 45% among women. While avoidable cancer mortality is
dominated by preventable cancer deaths among males, amenable
cancer deaths are more prominent among females.
For men, preventable cancer mortality decreased by 29% in
Eastern Germany, 34% in Northwestern Germany, and about
36% in Southwestern Germany between 1991 and 2013 (see
Table A2). The relative decrease in amenable cancer mortality
is similar among men: 28% in Eastern Germany, 32% in
Northwestern Germany, and 36% in Southwestern Germany.
Among women, however, the trend in preventable cancer
mortality is diametrically opposed as there is an overall increase
in all three regions. Amounting to 27%, the relative growth in
preventable mortality is more present in Northwestern Germany,
compared to 19% in Southwestern Germany and 1.4% in
Eastern Germany. With regard to amenable cancer mortality, the
pattern for women is similar compared to men, but showing a
slightly higher relative decline: 40% in Eastern Germany, 35% in
Northwestern Germany, and 37% in Southwestern Germany.
Furthermore, we find remarkable sex-specific differences in
preventable cancer mortality (Figure 2A) at the regional level. For
men, in spite of a strong decrease in all regions, there is still a
considerable east-west divide in the northern half of Germany
but there is also an even more significant north-south divide
in Western Germany. In 2013, preventable cancer mortality
was significantly higher in Eastern (+32%) and Northwestern
Germany (+25%) than in Southwestern Germany among men,
approved by mortality rate ratios calculated on the basis of
the standardized death rates (see Table A3). Among women,
however, preventable cancer mortality has increased in all of
Western Germany since reunification but had decreased in
Eastern Germany until the late 2000s and since then it has
almost converged to the pattern of Southwestern Germany.
In comparison to Southwestern Germany, preventable cancer
mortality was significantly higher for women in Northwestern
(+34%) and Eastern Germany (+4%) at the end of the
observation period.
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FIGURE 2 | Preventable and amenable cancer deaths per 100,000 in Northwestern, Southwestern, and Eastern Germany (standardized death rate, ages 0–74, years
1991–2013, 3 year values with 95% confidence intervals). (A) Preventable cancer mortality. (B) Amenable cancer mortality.
Regarding amenable cancer mortality (Figure 2B), regional
disparities for men and women are considerably smaller. The
known east-west divide still dominates among men (+12% in
Eastern Germany and +5% in Western Germany compared
to the southwest in 2013) but a north-south gradient in
Western Germany has developed in recent years as well. Among
women, the pattern has become increasingly determined by
a north-south gradient in Western Germany. In comparison
to the southwest, amenable cancer mortality was significantly
higher in the northwest (+6%), while Eastern Germany (−3%)
showed the lowest level among the three regions in the last year
of observation.
Dividing amenable cancer mortality into sex-specific and
other cancer deaths, the level in sex-specific amenable cancer
mortality is generally lower in men than in women since men-
specific cancers are less frequent and less likely fatal than women-
specific cancers (Figure 3A). Among men, there is a significant
north-south divide to the advantage of the southwest but no
systematic differences between Northwestern (+13% in 2013
compared to the southwest) and Eastern Germany (+15%).
Among women, however, the pattern is completely different:
Northwestern Germany (+5%) showed the highest rates, while
Eastern Germany (−7%) showed the lowest values in comparison
to the southwest.
Referring to other amenable cancer deaths (Figure 3B), the
regional pattern which favors men and women in Southwestern
Germany and disadvantages men in Eastern Germany and
females in Northwestern Germany becomes visible again.
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FIGURE 3 | Sex-specific and other amenable cancer deaths per 100,000 in Northwestern, Southwestern, and Eastern Germany (standardized death rate, ages 0–74,
years 1991–2013, 3 year values with 95% confidence intervals). (A) Sex-specific amenable cancer mortality. (B) Other amenable cancer mortality.
All in all, the analyses show that the “traditional” east-
west gap in avoidable cancer mortality is still evident among
men, while the north-south gradient has gained importance,
with tendency to higher regional diversity. Among women, the




Down warding drifts in smoking prevalence for sex and between
geographical regions are used to explain the lung cancermortality
disparities in Germany which are mostly responsible for the
decline in preventable cancer mortality (30–32). Hence, some
regional disparities in preventable cancer mortality for men and
women remain evident. In contrast to the “traditional” east-
west gradient (33, 34) in preventable cancer mortality, some
regions in the East, especially for women, have not exceeded these
regional mortality disadvantages as we know from males for the
last decade.
With respect to the recent regional cluster affiliations, the
female preventable cancer mortality, e.g., for the state of Sachsen,
are more likely to take over the regional pattern of Southwestern
Germany with more similarities to States of Bayern and Baden-
Württemberg and Hessen (all three in vanguard position in
preventable mortality) than to other regions in Northwestern
Germany (including Bremen, Hamburg, Niedersachsen,
Nordrhein-Westfalen, Schleswig-Holstein, Rheinland-Pfalz,
Saarland). The assimilation process in Eastern Germany to
the Southwestern German pattern can be explained with the
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loss of demographic impact of those age groups with high
smoking epidemic in Eastern German women. Female Cohorts
born between 1946 and 1950 have not showed any significant
differences in smoking behavior in East Germany regarding
their educational status (35). But women in West Germany
predominantly have a higher smoking risk at the same time.
A recent study on the future perspective in smoking-
related mortality in Germany (36) argues that the east-west
convergence and especially the female mortality advantage in
Eastern Germany in lung cancer-related mortality is caused by
women born in the 1940s and 1950s who showed a comparatively
low smoking prevalence. Possibly, the contemporary mortality
advantage for women in Eastern Germany will change to the
opposite as younger cohorts of Eastern German women show
much higher smoking rates in comparison to both, previous
cohorts and the West (36, 37).
The female lung cancer epidemic affecting the younger
cohorts can be approximated. For women, a greater excess
mortality for lung cancer is more plausible because of the
increasing dominance of higher lung cancer rates in young and
middle-aged women (36–38).
The remaining gender gap in preventable cancer mortality is
due to lower risks of premature mortality in women. Moreover,
the majority of women’s sex-specific are amenable cancer deaths
is dominated by breast cancer. For men, more unfavorable life-
style risk factors including social and health behavior need to
be examined to analyze male excess mortality (39, 40). Those
risk factors are largely avoidable and contribute to the human,
social, and economic burden that is largely invisible in the
epidemiologic literature.
Amenable Cancer Mortality
Amenable cancer mortality in Germany is also directed by
colon/bowel cancer in men and breast cancer in women. The
regional pattern in amenable deaths from cancer is more
likely driven by the north-south gradient than by the east-
west gap. Overall, the most favorable trends in amenable cancer
mortality are still driven by improved therapeutic procedures and
advancements in diagnosis and screening that positively affects
typically more female cancers. A study from Brenner et al. (41)
supports the general improvement in bowel cancer for men and
women. After the introduction of screening colonoscopy starting
at age 55 years in Germany, the incidence and mortality of bowel
cancer have declined in the first decade of the twenty-first century
(41). Although the mortality in bowel cancer has systematically
declined for both sexes, females exhibit a survival benefit in this
type of cancer compared to males. This can be explained the
higher willingness of participation in cancer screening programs
of women and their appropriated compliance during cancer
therapy (41–43).
The most positive trends in amenable cancer mortality are
revealed in breast cancer in Germany, because of tremendous
improvement in treatment strategies of these cancer sites that
had similar benefits for women in East and West Germany
(44–47). Although breast cancer is defined as amenable cancer,
there is a remaining gap between East and West Germany with
unexpected lower incidences and mortality in breast cancer for
the East. Those are not typically results only from improvements
in therapeutic effects. Thereof, these regional disparities are
explained with the variability in reproductive histories for East
and West German women (48, 49). East German women born
in the 1950s and 1960s were less frequently childless and their
mean age at first childbirth was 5 years below the value for West
German women (50). These two characteristics are important
preventive factors in connection with breast cancer (49).
In addition, Eastern Germany, especially the federal state
of Sachsen, took over a vanguard position in establishing
regional (centralized) cancer registries including certified
tumor centers/boards, which should positively affect the
amenable cancer mortality trends. Consequently, there is a
clear regional pattern in breast cancer mortality with the
lowest mortality rates being found in Eastern Germany
(Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen,
Sachsen-Anhalt, Thüringen) and the highest mortality rates in
Northwestern Germany (including Schleswig-Holstein, Bremen,
Hamburg, Niedersachsen) (51–53). Among women, there is
a significant divide between Northwestern Germany and the
other two study regions that is probably about to even increase
in the near future. Thus, there is an evidence of a manifested
Northwest-Southeast divide in amenable and preventable cancer
mortality among women.
Limitations
This study has applied a specific approach to capture the
unique difficulties in defining avoidable cancer mortality for
the regional comparison in Germany. At the same time, we
recognized that some limitations remain. First, we could not
consider an additional set of variables, especially all risk factors
that were relevant in the development of avoidable cancer
mortality. Consequently, this important information on the
determinants of cancer mortality such as lifestyle (nutrition,
physical activity, alcohol consumption) or environmental
conditions (air pollution) was either not available for this recent
statistical analyses or was not considered to be representative
on the level of the three German super-regions. Socio-economic
factors, which significantly influence the relevant risk factors
and show considerable regional variations in Germany (40),
are not included in official German data. Second, we did
not use the data of the German cancer registries, which
are recorded by the Association of Population-Based Cancer
Registries (GEKID) and the Robert Koch Institute (RKI) every
two years (54). Actually, these data offer a more precisely
overview on cancer-related mortality and morbidity, such as
the prevalence of 27 selected cancer sites, but they are only
available for the period of 2004–2014 and not for all German
Länder and would therefore not match our analytical and
data setting.
Third, the long-term comparisons in cancer mortality are
affected by time lags. This involves new treatment/therapeutic
effects for amenable cancer mortality, developments in health
policy, and changes of health risk behaviors for preventable
cancer mortality, e.g., strict anti-smoking policy or healthy
food programs (55). Amenable cancer mortality is also a
quality benchmark for health care services. As an example,
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the advancement in treatment like adjuvant therapy or recent
reimbursement policy in pharmaceuticals may contribute to
the decline in cancer mortality. Fourth, we could not control
for selective migration between the German regions. This
phenomenon might be plausible to explain the healthy migrant
effect and even the changes in exposure of health risks in
some regions.
CONCLUSIONS
Generally, our study showed that regional disparities in avoidable
cancer mortality are more related to differences in risk-relevant
behavior than differences in the effectiveness of health care.
Regional differences in avoidable cancer mortality in Germany
were much more significant among men, where the traditional
east-west gradient was still evident. However, a general north-
south divide was also evident and is especially significant
in preventable cancer mortality among men. By contrast, a
north-south gradient in Western Germany meanwhile was
determined as the avoidable cancer mortality pattern among
women particularly led to an alignment of Eastern Germany
to the level of Southwestern Germany. Whereas, the male
pattern could be explained by higher rates of smoking and
alcohol abuse in the East, the female pattern was largely
attributed to the high smoking rates of younger, especially
Northwestern German cohorts who increasingly reach the
cancer-relevant age.
There were structural deficits in Northwestern and Eastern
Germany compared to the Southwest regarding the effectiveness
of health care that however didn’t touch Eastern German women
that much, presumably because they were less often childless and
thus less affected by breast cancer.
The regional pattern in avoidable cancer mortality has become
much more diverse, with decreasing importance of the east-west
gap and growing significance of a north-south divide.
German health policies should promote better access to
medical care in geographic areas with low population density,
especially in Eastern Germany and strengthen the improvement
of male-specific compliance in primary prevention. Another
provision should be the reduction of the male educational
disadvantage which consequently affects the health-related
lifestyle. Moreover, substantial investments in the labor market
strategies to reduce the selective migration of highly educated
young people from the east and north to the southern German
metropolitan areas have to be considered.
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APPENDIX
FIGURE A1 | All-cause premature mortality per 100,000 in Northwestern, Southwestern, and Eastern Germany (standardized death rate, ages 0–74, years
1991–2013, 3 year values with 95% confidence intervals).
TABLE A1 | Share of preventable and amenable cancer deaths in all-cause mortality at ages 0–74 in 1991 and 2013 for men and women in Northwestern,
Southwestern, Eastern, and total Germany (in %).
Preventable cancer mortality Amenable cancer mortality Total avoidable cancer mortality
Total Sex-specific Other
Men 1991
Southwest 15,6 7,9 2,3 5,6 31,4
Northwest 17,4 7,2 2,1 5,1 31,8
East 13,7 5,8 1,6 4,3 25,3
Total Germany 15,9 7,1 2,0 5,0 30,0
Men 2013
Southwest 17,0 8,7 2,5 6,2 34,3
Northwest 18,4 7,8 2,4 5,4 34,1
East 18,0 7,7 2,3 5,5 33,4
Total Germany 17,9 8,1 2,4 5,7 34,0
Women 1991
Southwest 8,1 17,9 10,8 7,1 43,8
Northwest 7,0 18,8 11,4 7,4 44,7
East 6,1 13,8 8,2 5,6 33,7
Total Germany 7,2 17,0 10,3 6,8 41,3
Women 2013
Southwest 12,8 18,4 11,8 6,5 49,5
Northwest 14,6 16,5 10,6 6,0 47,7
East 12,3 16,4 10,2 6,2 45,0
Total Germany 13,5 17,1 10,9 6,2 47,7
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TABLE A2 | Relative trend in preventable and amenable cancer mortality and all-cause mortality at ages 0–74 between 1991 and 2013 for men and women in
Northwestern, Southwestern, Eastern, and total Germany (in %).
Preventable cancer mortality Amenable cancer mortality Premature all cause mortality
Total Sex-specific Other
Men
Southwest –35,8 –35,7 –36,6 –35,3 –41,2
Northwest –33,8 –31,9 –28,8 –33,2 –37,6
East –29,1 –28,2 –21,2 –30,8 –46,0
Total Germany –33,5 –32,4 –30,2 –33,3 –40,9
Women
Northwest +26,9 –34,8 –31,0 –40,7 –29,6
Southwest +18,5 –36,6 –32,8 –42,5 –35,0
East +1,4 –40,3 –37,3 –44,6 –49,6
Total Germany +18,2 –36,7 –33,0 –42,2 –36,8
TABLE A3 | Ratio of the standardized death rates in preventable and amenable cancer mortality and all- cause mortality at ages 0–74 in 1991 and 2013 for men and
women in Northwestern, Southwestern, Eastern, and total Germany.
Preventable cancer mortality Amenable cancer mortality Premature all cause mortality
Total Sex-specific Other
Men 1991
Southwest 1 1 1 1 1
Northwest 1,22 0,99 1,00 0,98 1,09
East 1,20 1,00 0,92 1,04 1,36
Total Germany 1,14 1,00 0,99 1,00 1,12
Men 2013
Southwest 1 1 1 1 1
Northwest 1,25 1,05 1,13 1,01 1,16
East 1,32 1,12 1,15 1,11 1,25
Total Germany 1,18 1,05 1,09 1,03 1,12
Women 1991
Southwest 1 1 1 1 1
Northwest 1,26 1,03 1,02 1,04 1,09
East 1,22 1,03 1,00 1,06 1,40
Total Germany 1,16 1,02 1,01 1,03 1,13
Women 2013
Southwest 1 1 1 1 1
Northwest 1,35 1,06 1,05 1,08 1,18
East 1,04 0,97 0,93 1,03 1,08
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